Biblio Discovery — Demo Discovery Service

13 hasil untuk "Angelo Ferrantelli"

Menampilkan 1–13 · 0,27 detik · RSS

  1. Artikel Jurnal

    Corrigendum: SGLT2 inhibitor role in cardio-metabolic–renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications

    Mario Manunta; Giacomo Matteo Bruno; Angelo Ferrantelli dkk.

    Drugs in Context, Vol. 15 · 2026 · Inggris · DOAJ Scopus

    The authors wish to make the following corrections to their article: Manunta M, Bruno GM, Ferrantelli A, Ramirez RF, Nardi F. SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications. Drugs Context…

  2. Artikel Jurnal

    SGLT2 inhibitor role in cardio-metabolic-renal diseases: a narrative review of recent evidence and their pharmacological, clinical and economic implications

    Mario Manunta; Giacomo Matteo Bruno; Angelo Ferrantelli dkk.

    Drugs in Context, Vol. 15 · 2026 · Inggris · DOAJ Scopus

    Cardio-metabolic-renal (CMR) conditions, including type 2 diabetes mellitus, cardiovascular disease and chronic kidney disease, represent some of the most pressing public health challenges of the 21st century. In recent years, sodium–glucose co-transporter 2 (SGLT2) inhibitors (SGLT2is) have…

  3. Artikel Jurnal

    Does Systematic Preliminar Colour Doppler Study Reduce Kidney Biopsy Complication Incidence?

    Antonio Granata; Fulvio Floccari; Angelo Ferrantelli dkk.

    International Journal of Nephrology, Vol. 2011 · 2011 · Inggris · DOAJ Scopus

    While ultrasonography is widely performed prior to biopsy, colour Doppler examination is often used only to discover post-biopsy complications. Aim of this paper was to evaluate the usefulness of colour Doppler examination in planning the optimal site of puncture for renal biopsy. Present analysis…

  4. Artikel Jurnal Teks lengkap

    Acute kidney injury in a patient with metabolic syndrome

    Gioacchino Li Cavoli; Rita Passantino; Angelo Ferrantelli dkk.

    BioImpacts, Vol. 5 No. 3 · 2015 · Inggris · DOAJ Scopus

    Introduction: The metabolic syndrome (MS) encompasses many metabolic abnormalities and the insulin resistance is considered as one of the most significant denominators. The chronic kidney disease (CKD) is an emerging health problem but only few patients would reach the end stage renal disease…

  5. Artikel Jurnal

    Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

    Francesco Scolari; Elisa Delbarba; Domenico Santoro dkk.

    Journal of the American Society of Nephrology · 2021 · Inggris · OpenAlex Scopus

    Significance Statement A cyclic regimen of corticosteroid and cyclophosphamide is the first-line therapy for membranous nephropathy. Rituximab is superior to conservative treatment and noninferior to cyclosporine in inducing remission; it also may have a more favorable safety profile compared with…

  6. Artikel Jurnal

    Missing Opportunity for Nephroprotective Therapy in Patients With Non-Dialysis CKD Under Stable Nephrology Care

    Luca De Nicola; Chiara Ruotolo; Gaetano La Manna dkk.

    Kidney International Reports, Vol. 11 No. 6 · 2026 · Inggris · DOAJ Scopus

    Introduction: Awareness of the implementation of guideline-directed nephroprotective therapy is an essential preliminary step to optimize implementation of nephroprotective strategies in nondialysis chronic kidney disease (CKD) (ND-CKD). However, updated information on this issue is lacking in the…